Levodopa elevates homocysteine: is this a problem?

Arch Neurol. 2004 May;61(5):633-4. doi: 10.1001/archneur.61.5.633.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Brain / pathology
  • Homocysteine / blood*
  • Humans
  • Levodopa / adverse effects*
  • Levodopa / therapeutic use
  • Parkinson Disease / drug therapy
  • Peripheral Nervous System Diseases / etiology
  • S-Adenosylmethionine / metabolism*

Substances

  • Antiparkinson Agents
  • Homocysteine
  • Levodopa
  • S-Adenosylmethionine